This cohort study evaluates stroke and major bleeding rates before and after switching from warfarin to a direct oral anticoagulant (DOAC) in patients grouped by pre-switch time-in-therapeutic range guideline thresholds.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284330 | PMC |
http://dx.doi.org/10.1001/jamanetworkopen.2022.22089 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!